🔍 Intelligence Synthesis JP/EN
Ethics · Regulation · Technology — Pharma Practice Notes

AI and Cancer Research ── Lung ── 2026-09-30

A balance scale weighs one lone stone against stacked translucent glass layers, with light threads showing reasoning; it tips only slightly, suggesting AI aids but does not decide.
What this means, as an image (AI-generated, GPT Image): Lung oncologists can add explainable AI predictions to PD-L1-based treatment choices, but only as support for judgment.Download image (PNG, 2000×800)
Three new lung cancer AI papers shown side by side. The first covers immunotherapy selection, using 2,396 real-world patients, with AUC up to 0.77 in the test set and a drop in external validation. The second predicts EGFR mutation from CT with multi-task deep learning, and its score was tied to survival. The third predicts EGFR status in brain metastases in a multicenter study, with accuracy of 83.0% in 94 validation lesions. Readers compare target, method and validation.
Image abstract — the whole article on one page (click to enlarge)
3 Lung papers. Lead: Clinical usability of an explainable AI decision support tool and evaluation of multimodal models in NSCLC.

Journals covered and how papers are chosen: see the index

Lung cancer: treatment, trials and AI

← Back to this issue